Bander NH - Search Results

1

Infrequent ras oncogene point mutations in renal cell carcinoma.

Nanus DM, Mentle IR, Motzer RJ, Bander NH, Albino AP. Nanus DM, et al. Among authors: bander nh. J Urol. 1990 Jan;143(1):175-8. doi: 10.1016/s0022-5347(17)39905-6. J Urol. 1990. PMID: 2403598

2

Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression.

Nanus DM, Ebrahim SA, Bander NH, Real FX, Pfeffer LM, Shapiro JR, Albino AP. Nanus DM, et al. Among authors: bander nh. J Exp Med. 1989 Mar 1;169(3):953-72. doi: 10.1084/jem.169.3.953. J Exp Med. 1989. PMID: 2494294 Free PMC article.

3

Renal-cell carcinoma.

Motzer RJ, Bander NH, Nanus DM. Motzer RJ, et al. Among authors: bander nh. N Engl J Med. 1996 Sep 19;335(12):865-75. doi: 10.1056/NEJM199609193351207. N Engl J Med. 1996. PMID: 8778606 Review. No abstract available.

4

Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein.

Nanus DM, Pfeffer LM, Bander NH, Bahri S, Albino AP. Nanus DM, et al. Among authors: bander nh. Cancer Res. 1990 Jul 15;50(14):4190-4. Cancer Res. 1990. PMID: 2364374

5

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression.

Gastl GA, Abrams JS, Nanus DM, Oosterkamp R, Silver J, Liu F, Chen M, Albino AP, Bander NH. Gastl GA, et al. Among authors: bander nh. Int J Cancer. 1993 Aug 19;55(1):96-101. doi: 10.1002/ijc.2910550118. Int J Cancer. 1993. PMID: 8344757

6

Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A.

Nanus DM, Engelstein D, Gastl GA, Gluck L, Vidal MJ, Morrison M, Finstad CL, Bander NH, Albino AP. Nanus DM, et al. Among authors: bander nh. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7069-73. doi: 10.1073/pnas.90.15.7069. Proc Natl Acad Sci U S A. 1993. PMID: 8346219 Free PMC article.

7

Aminopeptidase A expression and enzymatic activity in primary human renal cancers.

Nanus DM, Bogenrieder T, Papandreou CN, Finstad CL, Lee A, Vlamis V, Motzer RJ, Bander NH, Albino AP, Reuter VE. Nanus DM, et al. Among authors: bander nh. Int J Oncol. 1998 Aug;13(2):261-7. doi: 10.3892/ijo.13.2.261. Int J Oncol. 1998. PMID: 9664120

8

Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen.

Bander NH, Trabulsi EJ, Kostakoglu L, Yao D, Vallabhajosula S, Smith-Jones P, Joyce MA, Milowsky M, Nanus DM, Goldsmith SJ. Bander NH, et al. J Urol. 2003 Nov;170(5):1717-21. doi: 10.1097/01.ju.0000091655.77601.0c. J Urol. 2003. PMID: 14532761 Clinical Trial.

9

DNA-mediated gene transfer of a human cell surface 170-kilodalton glycoprotein. Evidence for association with an endogenous murine protein.

Kantor RR, Bander NH, Finstad CL, Graf LH Jr, Lloyd KO, Old LJ, Albino AP. Kantor RR, et al. Among authors: bander nh. J Biol Chem. 1987 Nov 5;262(31):15166-71. J Biol Chem. 1987. PMID: 3312201 Free article.

10

Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen.

Nanus DM, Milowsky MI, Kostakoglu L, Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Bander NH. Nanus DM, et al. Among authors: bander nh. J Urol. 2003 Dec;170(6 Pt 2):S84-8; discussion S88-9. doi: 10.1097/01.ju.0000095151.97404.7c. J Urol. 2003. PMID: 14610416 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters